RxTally.CA — Canadian maple leaf logoClarity in every comparison.
CANADIAN MEDICATION GUIDE

How to find a drug’s DIN in Canada

By RxTallyLast Update 5 min read
THE QUICK ANSWER

What is a DIN number in Canada?

A Drug Identification Number (DIN) is an eight-digit Health Canada identifier for a specific drug product. Look for “DIN” on the original carton, then match all eight digits—including the leading zero—to the official product record.

Where is the DIN on my box or pharmacy label?

Start with the original manufacturer’s carton. Look for the letters DIN followed by eight digits. Check more than one panel: the number may be away from the barcode, and its position varies by product.

If you have only a pen, keep it with its carton when possible. The carton is usually the easiest place to read the full product information. Do not assume the DIN is never printed on a pen, or try to identify a product from the pen colour alone.

Your pharmacy label, official prescription receipt or medication expense report may also show a DIN. If you see a PIN or prescription number instead, ask the pharmacist to identify the manufacturer’s DIN for the product actually supplied. A receipt’s DIN/PIN field is not always a DIN.

01 · ORIGINAL CARTON

Look for “DIN”

Read all eight digits on the manufacturer’s label. Look across the carton’s panels rather than assuming it is beside the barcode.

02 · PHARMACY PAPERWORK

Check what the field means

A receipt may say DIN/PIN. Ask whether the number is the product’s DIN or a plan’s billing identifier.

03 · ONLY HAVE THE PEN?

Ask the dispensing pharmacy

Keep the pen and any packaging together. The pharmacist can identify the supplied product from the dispensing record.

How to check a DIN in Health Canada’s database

Use the complete eight-digit number in Health Canada’s Drug Product Database (DPD). Keep the leading zero: 02540258 is a product identifier, not a number to shorten to 2540258.

Compare the manufacturer, product name, ingredient, strength, dosage form and route. Read the presentation description as well. A solution concentration, the total medicine in a pen and the dose it delivers describe different things.

Then read the status and the Canadian product monograph. In the DPD, Approved means authorized but not yet marketed; Marketed means recorded as being sold; Dormant means previously marketed with no sales for at least 12 consecutive months. None confirms that a particular pharmacy has stock, that your package is genuine, or that your insurer will pay.

Open Health Canada’s DIN search ↗

A worked example: the Ozempic DIN on your quote matters

Two quotes that both say “Ozempic 0.5 mg” can still leave an important detail unanswered. The original 1.5 mL pen and the 3 mL pen delivering 0.25 mg or 0.5 mg have different DINs and concentrations. Newer approved presentations add more distinctions.

For example, DIN 02540258 identifies the 2 mg/3 mL pen delivering 0.25 mg or 0.5 mg. DIN 02471469 identifies a 4 mg/3 mL pen delivering 1 mg doses. The 2 mg or 4 mg printed as pen content is not an instruction to inject that amount.

Six multidose pen records. A 2 mg pen is not the same description as a pen delivering a 2 mg dose. Approved and dormant records are included to help identify older or different presentations; they are not a claim of current supply.

Ozempic · Novo Nordisk
DIN / official recordProductLabelled dose / tablet strengthPresentationRecorded DPD status
02540258Ozempic0.25 mg or 0.5 mgMultidose pen · 2 mg/3 mL · 0.68 mg/mLMarketed
02471469Ozempic1 mgMultidose pen · 4 mg/3 mL · 1.34 mg/mLMarketed
02471477Ozempic0.25 mg or 0.5 mgMultidose pen · 2 mg/1.5 mL · 1.34 mg/mLDormant
02523930Ozempic2 mgMultidose pen · 8 mg/3 mL · 2.68 mg/mLApproved
02562618Ozempic0.25 mg or 0.5 mgMultidose pen · 4 mg/3 mL · 1.34 mg/mLApproved
02562626Ozempic1 mgMultidose pen · 8 mg/3 mL · 2.68 mg/mLApproved
Product and status sources
A REAL BRAND–GENERIC PAIR

Same comparison question. Two different DINs.

OzempicDIN 02540258

2 mg/3 mL multidose pen
0.25 mg or 0.5 mg labelled doses

Apo-Semaglutide InjectionDIN 02568020

2 mg/3 mL multidose pen
0.25 mg or 0.5 mg labelled doses

Ontario’s published interchangeability update links this exact pair. That gives you a specific question for your pharmacist—not permission to substitute any product called semaglutide.

Ask for a quote for each DIN with the same quantity and intended days of supply. Compare dispensing charges and your plan’s contribution separately. No assumed price or saving is needed to make the comparison precise.

Ontario’s published brand–generic pairs · Compare Ozempic prices →

Canadian GLP-1 DIN reference: choose your product

The tables below extend the Ozempic example to Wegovy, Mounjaro, Zepbound, Rybelsus and the named generic semaglutide products. Open a product group to see its records. The dose column identifies the labelled presentation; it is not a recommendation about which dose to use.

Use the exact product and format on your package. An approved presentation is not automatically available, and a Marketed status does not establish that a package is unaffected by a recall. The list covers the product families shown here, rather than every GLP-1 medicine or every future authorization in Canada.

58 DIN recordsIncludes the six Ozempic records above. Product identity and recorded status; no stock or coverage guarantee.
WegovyNovo Nordisk11 DINs

The six marketed multidose records include two different 0.5 mg pen presentations. Five separate single-dose pen records are Approved. Match the carton, not just the dose.

Wegovy · Novo Nordisk
DIN / official recordProductLabelled dose / tablet strengthPresentationRecorded DPD status
02528509Wegovy0.25 mgMultidose pen · 1 mg/1.5 mLMarketed
02528517Wegovy0.5 mgMultidose pen · 2 mg/1.5 mLMarketed
02552698Wegovy0.5 mgMultidose pen · 2 mg/3 mLMarketed
02528525Wegovy1 mgMultidose pen · 4 mg/3 mLMarketed
02528533Wegovy1.7 mgMultidose pen · 6.8 mg/3 mLMarketed
02528541Wegovy2.4 mgMultidose pen · 9.6 mg/3 mLMarketed
02522551Wegovy0.25 mgSingle-dose pen · 0.25 mg/0.5 mLApproved
02522578Wegovy0.5 mgSingle-dose pen · 0.5 mg/0.5 mLApproved
02522586Wegovy1 mgSingle-dose pen · 1 mg/0.5 mLApproved
02522594Wegovy1.7 mgSingle-dose pen · 1.7 mg/0.75 mLApproved
02522608Wegovy2.4 mgSingle-dose pen · 2.4 mg/0.75 mLApproved
Product and status sources
MounjaroEli Lilly18 DINs

KwikPens, single-dose vials and single-dose pens have separate DINs. A KwikPen supplies four fixed doses; a single-dose vial supplies one. Do not compare one vial with one four-dose pen as if they were equal quantities.

Mounjaro · Eli Lilly
DIN / official recordProductLabelled dose / tablet strengthPresentationRecorded DPD status
02551950Mounjaro KwikPen2.5 mg/0.6 mLMultidose pen · four fixed dosesMarketed
02551969Mounjaro KwikPen5 mg/0.6 mLMultidose pen · four fixed dosesMarketed
02551977Mounjaro KwikPen7.5 mg/0.6 mLMultidose pen · four fixed dosesMarketed
02551985Mounjaro KwikPen10 mg/0.6 mLMultidose pen · four fixed dosesMarketed
02551993Mounjaro KwikPen12.5 mg/0.6 mLMultidose pen · four fixed dosesMarketed
02552000Mounjaro KwikPen15 mg/0.6 mLMultidose pen · four fixed dosesMarketed
02541041Mounjaro2.5 mg/0.5 mLSingle-dose vial · one dose per vialMarketed
02541068Mounjaro5 mg/0.5 mLSingle-dose vial · one dose per vialMarketed
02541076Mounjaro7.5 mg/0.5 mLSingle-dose vial · one dose per vialMarketed
02541084Mounjaro10 mg/0.5 mLSingle-dose vial · one dose per vialMarketed
02541092Mounjaro12.5 mg/0.5 mLSingle-dose vial · one dose per vialMarketed
02541106Mounjaro15 mg/0.5 mLSingle-dose vial · one dose per vialMarketed
02532891Mounjaro2.5 mg/0.5 mLSingle-dose prefilled penApproved
02532905Mounjaro5 mg/0.5 mLSingle-dose prefilled penApproved
02532913Mounjaro7.5 mg/0.5 mLSingle-dose prefilled penApproved
02532921Mounjaro10 mg/0.5 mLSingle-dose prefilled penApproved
02532948Mounjaro12.5 mg/0.5 mLSingle-dose prefilled penApproved
02532956Mounjaro15 mg/0.5 mLSingle-dose prefilled penApproved
Product and status sources
ZepboundEli Lilly6 DINs

These Canadian records identify the four-dose KwikPen. Earlier records use the name Zepbound KwikPen; a later name change retained the same DINs. Mounjaro and Zepbound do not share DINs.

Zepbound · Eli Lilly
DIN / official recordProductLabelled dose / tablet strengthPresentationRecorded DPD status
02557509Zepbound2.5 mg/0.6 mLMultidose KwikPen · four fixed dosesMarketed
02557517Zepbound5 mg/0.6 mLMultidose KwikPen · four fixed dosesMarketed
02557525Zepbound7.5 mg/0.6 mLMultidose KwikPen · four fixed dosesMarketed
02557533Zepbound10 mg/0.6 mLMultidose KwikPen · four fixed dosesMarketed
02557541Zepbound12.5 mg/0.6 mLMultidose KwikPen · four fixed dosesMarketed
02557568Zepbound15 mg/0.6 mLMultidose KwikPen · four fixed dosesMarketed
Product and status sources
RybelsusNovo Nordisk6 DINs

Initial and optimized formulations have different strengths and DINs. They are not interchangeable milligram for milligram. Ask the pharmacist to confirm the formulation; this table is not a conversion guide.

Rybelsus · Novo Nordisk
DIN / official recordProductLabelled dose / tablet strengthPresentationRecorded DPD status
02497581Rybelsus — initial formulation3 mg tabletOral tabletMarketed
02497603Rybelsus — initial formulation7 mg tabletOral tabletMarketed
02497611Rybelsus — initial formulation14 mg tabletOral tabletMarketed
02551012Rybelsus — optimized formulation1.5 mg tabletOral tabletMarketed
02551020Rybelsus — optimized formulation4 mg tabletOral tabletMarketed
02551039Rybelsus — optimized formulation9 mg tabletOral tabletMarketed
Product and status sources
Generic semaglutideApotex, Dr. Reddy’s, Sandoz and Aspen11 DINs

There is no single generic semaglutide DIN. Match the manufacturer and reference product. Sevmia references Wegovy; the other named programs require their own product check. Separate Aspen product names and DINs are retained rather than merged. A Marketed record does not cancel a recall or confirm unaffected stock.

Generic semaglutide · Apotex, Dr. Reddy’s, Sandoz and Aspen
DIN / official recordProductLabelled dose / tablet strengthPresentationRecorded DPD status
02568020Apo-Semaglutide Injection · Apotex0.25 mg or 0.5 mgMultidose pen · 2 mg/3 mL · 0.68 mg/mLMarketed
02568012Apo-Semaglutide Injection · Apotex1 mgMultidose pen · 4 mg/3 mL · 1.34 mg/mLMarketed
02567806Semaglutide Injection · Dr. Reddy’s0.25 mg or 0.5 mgMultidose pen · 2 mg/1.5 mL · 1.34 mg/mLMarketed
02567814Semaglutide Injection · Dr. Reddy’s1 mgMultidose pen · 4 mg/3 mL · 1.34 mg/mLMarketed
02571501Sandoz Semaglutide0.25 mg or 0.5 mgMultidose pen · 1.34 mg/mLApproved
02571528Sandoz Semaglutide1 mgMultidose pen · 1.34 mg/mLApproved
02569582Sevmia · Apotex · Wegovy reference1 mgMultidose pen · 4 mg/3 mLApproved
02569930Aspen-Semaglutide0.25 mg or 0.5 mgMultidose pen · 1.34 mg/mLApproved
02569949Aspen-Semaglutide1 mgMultidose pen · 1.34 mg/mLApproved
02570920Semaglutide Injection · Aspen0.25 mg or 0.5 mgMultidose pen · 1.34 mg/mLApproved
02570912Semaglutide Injection · Aspen1 mgMultidose pen · 1.34 mg/mLApproved
Product and status sources

Read “Approved,” “Marketed” and “Dormant” as regulatory record labels. Even a marketed product may be unavailable locally. Check the exact carton and current record with your pharmacist.

Three conversations where the DIN does the work

A DIN is useful when it makes the next question precise. Read it aloud one digit at a time, keep the product description beside it, and ask for the answer in writing when comparing costs or coverage.

1. Requesting a pharmacy quote

“Could you quote DIN 02540258, including the quantity, days supplied and dispensing fee? If you are offering a generic, what is its manufacturer and DIN, and is the quote for the same supply?”

Keep the quote date and fee breakdown. A brand name alone can hide a different pen or package.

How to compare medication quotes →

2. Calling your insurer

“Is this exact DIN covered under my plan for my prescribed indication? Does it need prior authorization or generic substitution? What deductible, co-pay and annual limit would apply?”

Ask about the DIN the pharmacy expects to dispense. An answer about the brand may not apply to a later generic claim.

Prepare your coverage check →

3. Checking a recall

“My package shows this DIN, lot number and expiry. Does it match the affected product in this recall, and what action applies to the package I have?”

The August Apo-Semaglutide notice identifies DIN 02568020, lot 7000599A. The separate September notice identifies DIN 02568012, lot 7000636A. The manufacturer name alone would not distinguish those recalls.

Use the current official notice and speak with a pharmacist or healthcare provider before changing treatment. Do not interpret a DIN match alone as the recall’s complete scope.

How to read a recall notice →

DIN vs lot number, NDC, NPN and prescription number

The number beside a barcode is not necessarily the DIN. Neither is the pharmacy’s prescription number. Each identifier answers a different question, and a recall may require several of them together.

Different numbers, different jobs
IdentifierWhat it identifiesWhat to use it for
DINAn authorized Canadian drug product recordMatch product identity for quotes, insurance and product information.
Lot / batch numberA manufacturing batchMatch the affected batches in a recall; it is not a replacement for the DIN.
NDCA US drug product identifierUse the Canadian DIN when checking a Canadian product. An NDC does not replace Canadian authorization.
NPN / DIN-HMA licensed natural health or homeopathic productThese are different regulatory categories, not identifiers for an approved prescription semaglutide product.
Rx number / PINA pharmacy prescription record or plan billing identifierAsk the pharmacist which number is needed. Neither should automatically be treated as the manufacturer’s DIN.

What if the DIN is missing or the result does not match?

Ask a licensed pharmacist to resolve a missing or mismatched identifier before relying on the product description. Check for a mistyped digit, a pharmacy PIN, a different manufacturer or a different presentation. A familiar brand name and a plausible-looking number are not enough to authenticate a package.

For a standard manufactured Canadian prescription product, no matching authorization is a warning sign. But “no DIN visible on this label” is not the same finding. Compounded prescriptions and some pharmacy-dispensed labels have different labelling rules. A compounded preparation should not be presented as an approved generic merely because it contains the same ingredient.

Treat “research use only” offers, a number belonging to another medicine, or a seller unwilling to identify the supplying pharmacy as reasons to pause and ask a pharmacist. A copied DIN cannot make an unauthorized seller or counterfeit package legitimate.

Frequently asked questions

Where can I find the DIN on an Ozempic or other GLP-1 pen?

Start with the original carton and look for DIN followed by eight digits. Check the pen label too, but do not rely on pen colour or the dose window. If the carton is gone or the number is unclear, ask the dispensing pharmacy for the DIN on your prescription receipt or dispensing record.

Is a DIN always eight digits, including a leading zero?

Yes. Canadian DINs contain eight digits. Keep leading zeroes when copying or searching: 02540258 should remain an eight-character identifier.

Does generic semaglutide use the same DIN as Ozempic?

No. An authorized generic has its own product record and DIN. For example, Ozempic 02540258 and Apo-Semaglutide Injection 02568020 are different DINs. Ontario lists this particular pair as interchangeable; that does not make all semaglutide products interchangeable or authorize you to switch them yourself.

Why are there several Ozempic DINs?

Different presentations can have different concentrations, total pen contents and labelled delivered doses. The same brand name or a reference to a 0.5 mg dose does not identify every one of those details. Match the DIN and presentation on the actual carton.

Does a DIN prove my insurance will cover the medication?

No. It identifies the product for the coverage question. Your plan may also consider the indication, prior authorization, deductible, benefit limits and substitution rules. Ask the insurer about the exact DIN and your circumstances.

Can I use a DIN to check a medication recall?

Use the DIN to narrow the product, then match the lot number and any other identifiers in the official recall notice. A notice may affect one lot, several lots or a wider group. Follow the notice and ask your pharmacist or healthcare provider about the package you have.

Does a missing DIN mean my medicine is illegal?

Not by itself. The DIN may be on the original manufacturer’s packaging rather than the pharmacy-applied label. Compounded prescriptions also have different rules. Ask the pharmacist to identify exactly what was dispensed. A standard manufactured product being sold as an authorized Canadian medicine should have a matching authorization record.

Sources and methodology

RxTally matched DINs, product names and labelled presentations to Health Canada records, Canadian product monographs and the provincial records linked in the tables. The guide’s Last Update date records this editorial review; it is not an approval date or a pharmacy stock check.

Some Health Canada product pages could be reviewed through indexed official records when direct retrieval was unavailable. We have kept the recorded statuses distinct from retail availability. Open the current official record and confirm the actual package with your pharmacist if a detail has changed.

Product-specific sources sit below each table. Ontario’s interchangeability example applies to the identified pair and province; it is not a national substitution rule. This reference does not calculate a dose, recommend a switch or verify a seller.

USE THE NUMBER

Turn the right product into a useful comparison.

Once the pharmacy confirms your DIN, compare the quote, check the plan’s rules and ask whether a manufacturer card applies to that exact product.